DHR

NYSE · Life Sciences Tools & Services

Danaher Corp

S&P 500 Large-Cap Stocks Blue Chip Stocks Healthcare Stocks Best Dividend Stocks

$161.91

-2.63 (-1.60%)

As of May 16, 1:01 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Very High

Coverage

Buy 26 87%

Hold 4 13%

Sell 0 0%

Price Target

Analyst Price Target -2.3% upside

Low Target $107.89

Average Target $158.11

High Target $252.83

Current Price $161.91

Current
$161.91

Target
$158.11

$107.89 $158.11 avg $252.83

Scenario Analysis

Bear Case

$107.89

-33.4%

Low target

Base Case

$158.11

-2.3%

Avg target

Bull Case

$252.83

+56.2%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$242.80

-33.3% from high

52-Week Low

$163.32

+-0.9% from low

50-Day SMA

$227.23

-28.7% vs SMA

200-Day SMA

$209.48

-22.7% vs SMA

RSI (14)

39.9

Neutral

Target vs 52W High

$158.11

-34.9% vs high

Peer Consensus — Life Sciences Tools & Services

Stock	Consensus	Analysts	Buy %	Target	Upside
TMO Thermo Fisher Scientific Inc	Strong Buy	34	88%	$369.21	-15.8%
DHR Danaher Corp	Strong Buy	30	87%	$158.11	-2.3%
WAT Waters Corp	Buy	28	57%	$189.60	-42.4%
A Agilent Technologies Inc	Strong Buy	28	79%	$64.69	-42.1%
IQV Iqvia Holdings Inc	Strong Buy	31	87%	$82.96	-50.9%
ILMN Illumina Inc	Hold	28	54%	$169.36	+18.8%
WST West Pharmaceutical Services	Strong Buy	23	78%	$136.24	-55.0%
MTD Mettler-Toledo International	Hold	21	48%	$170.43	-83.5%